Framingham Heart Study
| Short Name | FHS
|
|---|---|
| Institution(s) |
Boston University
|
| Type of Omics | WGS
RNASeq
Metabolomics
Proteomics
Methylomics
|
| Approx. Sample Size | 4089wgs (ph1), 1861rnaseq (ph5), 3400metab (ph5), 1900methyl (ph5) |
| Starting Phase | Phase 1
|
| TOPMed Accession # |
Please see this TOPMed Project's Parent Studies.
|
| Omics Center(s) Phase 1 |
Broad Institute Genomics Platform
|
| Omics Center(s) Phase 5 |
Broad Institute Metabolomics Platform
Keck MGC
Northwest Genomics Center
|
| Specify the TOPMed Phase for the Omics Center(s) selected above |
pilot, 4.5, 5.5-5.6, 6 backfill
|
| Phases Involved |
1
5
Other Funding
|
| Populations |
European ancestry
|
| Co-PI | |
| Phenotype Liaison | |
| Steering Committee Representatives | Nancy Heard-Costa
Vasan S. Ramac…
Andrew Johnson
|
| P&P primary | |
| P&P alternate | |
| Project |
AFGen
|
Back to top
